UP

Oxford/AstraZeneca Covid vaccine 'dose error' explained

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto

On Monday, the world heard how the UK's Covid vaccine - from AstraZeneca and Oxford University - was highly effective in advanced trials.

Axar.az reports that it gave hope of another new jab to fight the pandemic that should be cheaper and easier to distribute than the Pfizer/BioNTech and Moderna mRNA vaccines that announced similarly impressive results just days before.

But after the jubilation, some negative press has followed.

On Thursday, multiple news outlets in the UK and the US reported that there were questions over the data. They weren't about safety, but rather how effective the jab is.

The questions center around efficacy levels.

Three were reported from the trial - an overall efficacy of 70%, a lower one of 62%, and a high of 90%.

That's because different doses of the vaccine were mistakenly used in the trial. Some volunteers have given shots half the planned strength, in error. Yet that "wrong" dose turned out to be a winner.

Date
2020.11.27 / 23:57
Author
Axar.az
See also

Scientists discover new coronavirus

Azerbaijan performs first deceased donor organ transplants

Fifty countries affected by USAID freeze - WHO

Monkeypox case confirmed in Azerbaijan

WHO calls for international support to fund aid in Gaza

30 metapneumovirus cases reported in Kazakhstan

Human metapneumovirus epidemic reported in China

WHO marks 5 years of COVID-19 and ongoing efforts

Expert warns of public health emergency in Delhi

Gaza polio vaccinations resume after clinic strike

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla